BioSpace News Archive

Masimo announced the results of a study published in Pneumonia in which independent researchers in New Delhi, India, investigated the accuracy of Masimo RRp® on pediatric patients with the Rad-G™ Pulse Oximeter by comparing it to clinician-determined values while performing routine assessment of children admitted to outpatient and emergency departments.

Medivir AB announced that it has entered a research collaboration with the Drug Discovery and Development Platform at SciLifeLab on potential inhibitors of SARS CoV-2.

Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization, announces Yuk Chun Chiu as Vice President of Manufacturing Operations.

SINOMED, a developer of innovative neuro- and cardiovascular technologies, announced the completion of the 1-year follow-up in the PIONEER-III, randomized global trial evaluating the BuMA Supreme Drug-Eluting Coronary Stent.

Cyxone, a Swedish biotech in autoimmune diseases, announces that the company has engaged Dr Maarten Kraan as Senior Scientific Advisor for the company’s project for Rabeximod in rheumatoid arthritis.

Vizient, Inc. has teamed up with medical suppliers to provide relief for hospitals from the strains of delivering patient care, monitoring and rehabilitation services brought on by COVID-19. The new resources and technology offerings address hospitals’ immediate and unique needs but are also designed as sustainable approaches to care delivery and improving patient satisfaction. Medtronic Care Management Services and Zimme

Emergent BioSolutions Inc. announced a five-year manufacturing services agreement with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, for large-scale drug substance manufacturing for Johnson & Johnson’s investigational SARS-CoV-2 vaccine, Ad26.COV2-S, recombinant based on the AdVac® technology.

Centogene N.V., a commercial-stage diagnostics and genetic research company, and the OESIS Network Inc, an innovation network of more than 600 schools across the U.S., announced a partnership for COVID-19 screening of schools.

Zhongchao Inc. (NASDAQ: ZCMD) (“Zhongchao” or the “Company”), an online provider of healthcare information, professional training and educational services to healthcare professionals and the public in China , today announced the official launch of patient management services (the “New Services”) as its third major line of business,

MiMedx Group, Inc., an industry leader in advanced wound care and an emerging therapeutic biologics company, announced the filing of its 2020 first quarter Form 10-Q.